Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Recruiting · NCT06333652 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders | Female Urogenital Diseases and Pregnancy Complications, Hemolysis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Recruiting | Phase 2 | 2026-04-28 | NCT06333652 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Minnesota | Rochester | United States | 40 |